Skip to main content
Cerinnov Group logo

Cerinnov Group — Investor Relations & Filings

Ticker · ALPCV ISIN · FR0013178712 LEI · 969500OPFO76AHWQEE53 PA Manufacturing
Open in API
Filings indexed 220 across all filing types
Latest filing 2022-03-04 Declaration of Voting R…
Country FR France
Listing PA ALPCV

About Cerinnov Group

https://www.cerinnov-group.com/

Cerinnov Group specializes in the design, manufacturing, and marketing of production and decorating machines for the ceramics and glass sectors. The company also provides equipment and kilns for the heat treatment industry. Its product portfolio includes shaping machines, laser systems, decoration equipment, and comprehensive turnkey production plants. Cerinnov Group delivers innovative and integrated solutions for advanced materials processing, catering to the specific requirements of its industrial clients.

Recent filings

Filing Released Lang Actions
Cerinnov Group: DECLARATION MENSUELLE DU NOMBRE D'ACTIONS ET DE DROITS DE VOTES
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled "DECLARATION MENSUELLE DU NOMBRE D'ACTIONS ET DE DROITS DE VOTES" (Monthly Declaration of the Number of Shares and Voting Rights) and is dated March 4, 2022, referencing the reporting date of February 28, 2022, and Article 223-16 of the AMF general regulation. This content specifically details the total number of shares and voting rights, which is a mandatory periodic disclosure in France. This type of periodic disclosure regarding share capital and voting rights does not fit neatly into the specific categories like 10-K, ER, or IR. It is a regulatory disclosure concerning capital structure and shareholder rights, but it is not a Director's Dealing (DIRS) or a Major Shareholding Notification (MRQ) which usually relate to changes in ownership thresholds. Given the options, the most appropriate classification for a mandatory, periodic regulatory filing that doesn't fit a more specific financial report type is the general 'Regulatory Filings' fallback category (RNS). However, since the content is directly about the total number of shares and voting rights, it is closely related to capital structure updates. Reviewing the definitions, none perfectly match a 'Monthly Share Capital Declaration'. Since it is a formal regulatory declaration about the capital structure, and RNS is the fallback for miscellaneous regulatory filings, RNS is the best fit among the provided codes.
2022-03-04 French
Cerinnov Group: Chiffre d'affaires 2021 en croissance de +40% à 10,2 M€
Earnings Release Classification · 98% confidence The document is titled with 'Chiffre d'affaires 2021' (2021 Revenue) and provides a detailed breakdown of revenue figures for the full year 2021, comparing them to 2020, segmented by business line (Equipments, Thermal Solutions, etc.). It explicitly states the revenue for the full year (10.2 M€) and includes a date stamp 'Communiqué de presse – 28 février 2022'. This structure—a press release announcing key, summarized financial results for a period—is characteristic of an Earnings Release (ER). It is not a comprehensive Annual Report (10-K) or a detailed Interim Report (IR), but rather the initial announcement of the results. FY 2021
2022-02-28 French
Cerinnov Group: DECLARATION MENSUELLE DU NOMBRE D'ACTIONS ET DE DROITS DE VOTES
Regulatory Filings Classification · 95% confidence The document is titled 'DECLARATION MENSUELLE DU NOMBRE D'ACTIONS ET DE DROITS DE VOTES' (Monthly Declaration of the Number of Shares and Voting Rights) and is dated February 3, 2022, with a closing date of January 31, 2022. It explicitly references Article 223-16 of the AMF (Autorité des Marchés Financiers) general regulation. This type of mandatory monthly disclosure detailing the total number of shares and voting rights is a standard regulatory filing in France, but it does not fit perfectly into the provided specific categories like 10-K, ER, or DIV. It is a specific regulatory disclosure concerning capital structure and voting rights. Given the options, it is closest to a general regulatory filing or a specific capital/share structure update. Since it is a mandatory periodic disclosure about the total share count and voting rights, it is best classified as a general Regulatory Filing (RNS) as it doesn't match the more specific definitions like Director's Dealing (DIRS) or Share Issue (SHA). However, since it is a declaration of the total number of shares and voting rights, it is a specific type of capital/share information disclosure. Given the options, RNS is the most appropriate fallback for a specific, non-standard regulatory report, although it touches upon share capital. I will use RNS as the best fit for a mandatory, periodic regulatory disclosure not covered elsewhere.
2022-02-03 French
Cerinnov Group: Calendrier de communication financière 2022
Report Publication Announcement Classification · 99% confidence The document is titled "Calendrier de communication financière 2022" (2022 Financial Communication Calendar) and lists specific future dates for the release of key financial information, such as 'Chiffre d'affaires' (Revenue) and 'Résultats annuels/semestriels' (Annual/Semi-annual results). This document is an announcement about *when* reports will be released, not the reports themselves. Since it is an announcement regarding the publication schedule of future reports, it fits best under the category for announcing report publication timing, which is Report Publication Announcement (RPA). The document is very short (1478 chars), supporting the 'MENU VS MEAL' rule suggesting it is an announcement rather than the full report.
2022-01-07 French
Cerinnov Group: DECLARATION MENSUELLE DU NOMBRE D'ACTIONS ET DE DROITS DE VOTES
Share Issue/Capital Change Classification · 95% confidence The document is titled 'DECLARATION MENSUELLE DU NOMBRE D'ACTIONS ET DE DROITS DE VOTES' (Monthly Declaration of the Number of Shares and Voting Rights) and is dated January 4, 2022, with a closing date of 31/12/2021. It explicitly references Article 223-16 of the AMF general regulation, which pertains to monthly share capital declarations in France. This type of mandatory periodic disclosure detailing the total number of shares and voting rights does not fit perfectly into the provided specific categories like 10-K, ER, or DIV. It is a regulatory disclosure concerning capital structure and voting rights, but it is not a Director's Dealing (DIRS), a Major Shareholding Notification (MRQ), or a general capital change (SHA). Given the options, the most appropriate general regulatory filing category for mandatory, periodic disclosures that don't fit elsewhere is 'Regulatory Filings' (RNS). However, since it specifically deals with the total number of shares and voting rights, it is a very specific type of regulatory filing. Reviewing the definitions, none perfectly match a 'Monthly Share Capital Declaration'. Since it is a mandatory regulatory filing that doesn't fit the other specific codes (like DIRS, MRQ, DIV, SHA), RNS is the best fallback. If a more specific code existed for 'Share Capital/Voting Rights Declaration', that would be used. Based on the provided list, RNS serves as the catch-all for mandatory regulatory announcements.
2022-01-04 French
Cerinnov Group: BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE
Capital/Financing Update Classification · 99% confidence The document is titled "BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE" (Semi-annual report on the liquidity contract) and reports the status of the liquidity contract as of December 31, 2021. It details the number of shares and cash held under the contract, and the transactions (purchases and sales) executed during the second half of 2021. This type of periodic reporting related to market stabilization or liquidity agreements, often mandated by financial regulators (like the AMF mentioned), is a specific type of regulatory disclosure. It is not a full Annual Report (10-K), an Interim Report (IR) detailing overall company financials, an Earnings Release (ER), or a Director's Dealing report (DIRS). Since it is a specific report detailing activity under a regulatory framework (liquidity contract), and it is not a general announcement of a report being published (RPA/RNS), it fits best under a specific category related to capital/financing activities or regulatory compliance. Given the options, this document is a periodic report detailing the execution and status of a specific financial arrangement (liquidity contract). While not explicitly listed, the closest fit among the provided codes that deals with specific financial arrangements or regulatory compliance related to share activity/capital management is often grouped with financing updates or regulatory filings. However, since it is a detailed, periodic report on a specific financial mechanism (liquidity contract), and not a general regulatory filing (RNS) or a general capital change (SHA), it requires careful mapping. Liquidity contracts are often related to share transactions. Since there isn't a perfect fit for 'Liquidity Contract Report', we must choose the best available option. It details share transactions and cash balances related to market support, which is a form of capital management/share activity reporting. Given the detailed nature and periodic reporting structure, it is more substantial than a simple announcement. If we consider the context of share transactions and capital management, 'Transaction in Own Shares (POS)' is related but this is about a contract, not the company directly buying back shares for its own account in the open market (though the contract facilitates this). 'Capital/Financing Update (CAP)' is plausible as it relates to managing share supply/demand. However, the most accurate general category for specific, periodic regulatory disclosures that don't fit elsewhere is often 'RNS' or, if it details specific share movements, sometimes 'POS' or 'SHA'. Given the focus on the liquidity contract execution, which involves buying/selling shares, and the lack of a specific 'Liquidity Report' code, 'POS' (Transaction in Own Shares) is a possibility if the contract is viewed as the mechanism for share repurchase/stabilization. However, 'RNS' (Regulatory Filings) is the safest fallback for specific, non-standard regulatory reports. Let's re-evaluate: This is a semi-annual report on a liquidity contract. This is a specific regulatory disclosure. It is not a general earnings report or management discussion. It is most accurately classified as a specific regulatory filing that doesn't fit the other detailed categories. Therefore, RNS is the most appropriate fallback.
2022-01-04 French

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.